The aim of the paper was to examine the echocardiographic parameters of the right ventricle (RV), its diameter and pulmonary arterial pressure (PAP); to determine their relationship to B-type natriuretic peptide (BNP), troponin and (TnI) and high-sensititity C-raective protein (hsCRP), and to evaluate their prognostic significance to one-year mortality in patients with acute heart failure (AHF). The study included a total of 225 patients (pts) (70.29 ± 9.74 years) who were admitted to Intensive care unit due to the signs and symptoms of AHF. The values of standard biochemical parameters, BNP, TnI and hsCRP were determined during the first 24 hours after admission. All patients underwent echocardiographic examination. During a one-year follow-up, 78 (34.70%) patients died. As compared with the group of survivors (n = 147), the group of non-survivors had higher values of BNP (853.10 ± 384.92 vs. 1399.68 ± 464.44 pg/mL, p < 0.001), TnI (0.59 ± 2.04 vs. 2.00 ± 8.29 ng/ml, p < 0.05), right ventricular diameter and PAP (p < 0.001). BNP was positively correlated with TnI (r = 0.311), PAP (r = 0.255) and right ventricular diameter (r = 0.304, p < 0.001 for all correlations). The cut-off value of BNP ≥ 1062.04 pg/ml, PAP ≥ 44.5 mmHg and TnI ≥ 0.04 ng/ml were associated with a higher risk of mortality. Our results have shown that BNP, PAP and TnI are strong and independent predictors of one-year mortality in hospitalized patients with acute heart failure.
References
1.
Siirila-Waris K, Lassus J, Melin J, Peuhkurinen K, Nieminen MS, Harjola VP, et al. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. European Heart Journal. 27(24):3011–7.
2.
Meyer P, Desai RV, Mujib M, Feller MA, Adamopoulos C, Banach M, et al. Right ventricular ejection fraction < 20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients. International Journal of Cardiology. 2012;155(1):120–5.
3.
Bistola V, Parissis JT, Paraskevaidis I, Panou F, Nikolaou M, Ikonomidis I, et al. Prognostic Value of Tissue Doppler Right Ventricular Systolic and Diastolic Function Indexes Combined With Plasma B-Type Natriuretic Peptide in Patients With Advanced Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy. The American Journal of Cardiology. 2010;105(2):249–54.
4.
Mariano‐Goulart D, Eberlé M, Boudousq V, Hejazi‐Moughari A, Piot C, de Kerleau CC, et al. Major increase in brain natriuretic peptide indicates right ventricular systolic dysfunction in patients with heart failure. European Journal of Heart Failure. 2003;5(4):481–8.
5.
Vogelsang TW, Jensen RJ, Monrad AL, Russ K, Olesen UH, Hesse B, et al. Independent effects of both right and left ventricular function on plasma brain natriuretic peptide. European Journal of Heart Failure. 2007;9(9):892–6.
6.
Segers VFM, Brutsaert DL, De Keulenaer GW. Pulmonary hypertension and right heart failure in heart failure with preserved left ventricular ejection fraction. Current Opinion in Cardiology. 2012;27(3):273–80.
7.
Burke MA, Katz DH, Beussink L, Selvaraj S, Gupta DK, Fox J, et al. Prognostic Importance of Pathophysiologic Markers in Patients With Heart Failure and Preserved Ejection Fraction. Circulation: Heart Failure. 2014;7(2):288–99.
8.
O’Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M. Demographics, Clinical Characteristics, and Outcomes of Patients Hospitalized for Decompensated Heart Failure: Observations From the IMPACT-HF Registry. Journal of Cardiac Failure. 2005;11(3):200–5.
9.
Araújo JP, Lourenço P, Azevedo A, Friões F, Rocha-Gonçalves F, Ferreira A, et al. Prognostic Value of High-Sensitivity C-Reactive Protein in Heart Failure: A Systematic Review. Journal of Cardiac Failure. 2009;15(3):256–66.
10.
Peacock WF, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, et al. Cardiac Troponin and Outcome in Acute Heart Failure. New England Journal of Medicine. 2008;358(20):2117–26.
11.
Bosseau C, Galli E, Donal E. Prognostic value of BNP in heart failure with preserved or reduced ejection fraction. Heart. 2015;101(23):1855–6.
12.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Journal of Heart Failure. 2016;18(8):891–975.
13.
Petrović D, Deljanin Ilić M, Ilić S, al. Prognostic significance of B-type natriuretic peptide and pulmonary arterial pressure in patients with acute heart failure. Eur J Heart Failure. 2017;19(Suppl. S1):392.
14.
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Heart Journal – Cardiovascular Imaging. 2015;16(3):233–71.
15.
McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Bohm M, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2012;33(14):1787–847.
16.
Mendes LA, Dec GW, Picard MH, Palacios IF, Newell J, Davidoff R. Right ventricular dysfunction: An independent predictor of adverse outcome in patients with myocarditis. American Heart Journal. 1994;128(2):301–7.
17.
Dickstein K, Cohen‐Solal A, Filippatos G, McMurray JJV, Ponikowski P, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008‡. European Journal of Heart Failure. 2008;10(10):933–89.
18.
Harjola V, Follath F, Nieminen MS, Brutsaert D, Dickstein K, Drexler H, et al. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. European Journal of Heart Failure. 2010;12(3):239–48.
19.
Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, et al. Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea. New England Journal of Medicine. 2004;350(7):647–54.
20.
Hobbs F. European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF). European Heart Journal. 2000;21(22):1877–87.
21.
Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, et al. EURObservational Research Programme: regional differences and 1‐year follow‐up results of the Heart Failure Pilot Survey (ESC‐HF Pilot). European Journal of Heart Failure. 2013;15(7):808–17.
22.
Petrovic D, Deljanin-Ilic M, Stojanovic S. Prognostic value of biomarkers and co-morbidities in patients with acute heart failure: One-year follow-up study. Srpski arhiv za celokupno lekarstvo. 2017;145(3–4):118–23.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
